Theragnostic Talks
Theragnostic Talks
SAM Nordic
Very welcome to Theragnostic Talks by SAM Nordic, the one and only podcast about theragnostic. What is even theragnostic? And what does the future for it look like? In this podcast we will find out interesting science and get answers to curious questions by talking with true experts - clinicians, scientists and people from the industry. And to guide you through these episodes – Annette Andrén and Gustav Widar. Annette is driven by the transformation of science into value for patients. Her background as a chemical engineer - with focus on biochemistry - has led her to different positions such as country manager and market access director in the Nordics. She has been working both within a large variety of different therapy areas and with breakthrough treatments for inflammation and autoimmune diseases. What she likes the most is when she is able to help out in the identification of scientific opportunities for collaborations between Health care, Research and the Industry. She is currently senior medical science liaison at SAM Nordic. Gustav has a background as a licensed medical physicist and has worked many years in the field of nuclear medicine – covering imaging, therapy and the production of radiopharmaceuticals. He is driven by making medical innovations a clinical reality – where it really benefits the patient care. A couple of years ago he changed from healthcare to industry, now medical science liaison at SAM Nordic.
ProPSMA and TheraP ­– changing patient care - with Michael Hofman
Professor Michael Hofman has contributed to some of the most important progress for imaging and treatment of prostate cancer. And his collaborative approach has brought together multi-disciplinary expertise from more than 10 centers around Australia. – If you have the energy to put together a clinical trial protocol I bet colleagues around your country will be happy to adopt it. It is a win-win for everyone. Please join us in this episode of Theragnostic Talks.   Guest: Prof. Michael Hofman By: Annette Andrén and Gustav Widar Contact us: [email protected] For more info, visit www.samnordic.se
Aug 18, 2021
53 min
The lucky, PET-addicted guy – with Stefano Fanti
By collaboration we can improve the scientific results and really make a difference. Don't miss this episode with the committed professor Stefano Fanti, devoted to his mission and always eager to spread the word about PET and prostate imaging. Ending up with breaking news about the EANM congress… Enjoy! Guest: Prof. Stefano Fanti By: Annette Andrén and Gustav Widar Contact us: [email protected] For more info, visit www.samnordic.se
Aug 5, 2021
54 min
Turned family loss to stronger patient voice – with Simone Leyden
When Simone Leyden lost her 34 year old sister in a rare GI cancer she and her brother John decided to start a foundation. What struck them, when their sister was struggling, was that there was a huge difference in treatment and support for less common cancers, compared to more common ones. Please join us and listen to this episode of Theragnostic Talks Simone, founder and CEO of NeuroEndocrine Cancer. Guest: Simone Leyden, co-founder and CEO NeuroEndocrine Cancer By: Gustav Widar & Annette Andrén Contact us: [email protected] For more info, visit www.samnordic.se
Jul 7, 2021
47 min
”This is the theragnostic breakthrough” – with Oliver Sartor, Bernd Krause and Ken Hermann
We gathered up with Oliver Sartor, Bernd Krause and Ken Hermann, co-authors of the VISION study, to talk about how it will impact the treatment of prostate cancer. The VISION study is the first international randomized open label phase III study that shows convincing results for a novel treatment of late-stage advanced prostate cancer. A targeted treatment for prostate cancer using radioactive 177Lu-PSMA-617. Successful? Without a doubt if you ask Oliver Sartor. – This is the theragnostic breakthrough we all have been waiting for. It's going to change the way we treat cancer. Join us on Theragnostic Talks!   Guest: Oliver Sartor, Bernd Krause, Ken Hermann By: Gustav Widar Contact us: [email protected] For more info, visit www.samnordic.se
Jun 23, 2021
34 min
ImmunoPET, predicting response to therapy - with Anna Wu
What is immunoPET and radio immunotherapy? Meet Anna Wu, professor at City of Hope and research professor at UCLA, California. She explains why antibodies can be used instead of small molecules or peptides, how to use immunoPET for patient selection in immunotherapy and why a revolution of precision health is on its way. Guest: Anna Wu By: Gustav Widar and Annette Andrén Contact us: [email protected] For more info, visit www.samnordic.se
Jun 9, 2021
58 min
Renaissance for radioligand therapy - with Germo Gericke
In 5 to 10 years we are going to use theragnostics predominantly in combination with other therapies. Why? Because it gives us the opportunity to treat cancer in a totally different way. It's also a step forward to more personalized treatment. In this episode of Theragnostic Talks you get to meet Germo Gericke, Medical Officer at AAA. Enjoy! We apologize for bad sound quality in the beginning of this episode, but hold on – it gets better after 10 minutes. Guest: Germo Gericke By: Gustav Widar and Annette Andrén Contact us: [email protected] For more info, visit www.samnordic.se
May 26, 2021
36 min
The PSMA take off - with Professor Louise Emmett
What professor Louise Emmett really loves is research. As a doctor, she says, you are able to change the lives for some people. With clinical research you can change the lives for millions of people. In this episode Louise Emmett explains theragnostics in prostate cancer and how prostate imaging can be used to understand the phenotype of the tumor. A step towards a more personalized treatment. Guest: Professor Louise Emmett By: Gustav Widar and Annette Andrén Contact us: [email protected] For more info, visit www.samnordic.se
May 12, 2021
1 hr 3 min
Kill them all - with Dr Oliver Sartor
What are the challenges for theragnostic to be successful in the future? And how can we turn theragnostic innovations into successful and available therapies? In this episode of Theragnostic Talks we talk to Dr Oliver Sartor, the world-renowned prostate cancer expert and leader of Tulane's Prostate Cancer Research Program. Please join!   Guest: Dr Oliver Sartor By: Gustav Widar and Annette Andrén Contact us: [email protected] For more info, visit www.samnordic.se
Apr 28, 2021
41 min
S01E03 Christian Behrenbruch
“For nuclear medicine to be widely successful you have to care about people everywhere. We need to come up with solutions that make nuclear medicine really accessible for everyone. And the reason why we should do that is because it has a great cost beneficial profile”. The serial entrepreneur Dr Christian Behrenbruch is co-founder and CEO of Telix Pharmaceuticals and our guest in this episode of Theragnostic Talks. Enjoy!   Guest: Dr Christian Behrenbruch By: Gustav Widar and Annette Andrén Contact us: [email protected] For more info, visit www.samnordic.se
Apr 14, 2021
49 min
S01E02 Rodney Hicks
What does the future look like for more personalized therapy? And is sometimes no treatment the best option? In this episode we continue talking to professor Rodney Hicks.
Mar 31, 2021
55 min
Load more